Brief: Enlivex Therapeutics Files For Offering Of Up To $299.6 Mln Of Ordinary Shares
24/11/2025 18:15
Nov 24 (Reuters) - Enlivex Therapeutics Ltd ENLV.TA: ENLIVEX THERAPEUTICS LTD - FILES FOR OFFERING OF UP TO $299.6 MILLION OF ORDINARY SHARES - SEC FILING Source text: [ID:n0001213900-25-113879] Further company coverage: ENLV.TA ((((Reuters.Briefs@thomsonreuters.com));))
Recent news on Enlivex
See all newsBrief: Enlivex Announces 1-For-16 Reverse Share Split To Be Effective October 27, 2026
Brief: Enlivex Announces $400,000,000 Private Placement
Brief: Enlivex Ltd Registers Up To 23,333,333 Ordinary Shares For Resale By Selling Shareholder
Brief: Enlivex Announces Second Regulatory Approval For Phase 2B Trial Of Allocetra In Age-Related Primary Moderate-To-Severe Knee Osteoarthritis
Brief: Enlivex Therapeutics Files For Offering Of Up To $299.6 Mln Of Ordinary Shares